Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Ionis Pharmaceuticals, Inc.(IONS) | 255,000 | 505,007 | +250,007 | $10.22M | $17.66M | 8.32% | +$7.44M |
| Cytokinetics, Incorporated(CYTK) | 316,000 | 360,000 | +44,000 | $16.68M | $16.93M | 7.98% | +$249.6K |
| Kalvista Pharmaceuticals Inc | 1,299,503 | 1,787,003 | +487,500 | $15.05M | $15.14M | 7.13% | +$87.7K |
| Viridian Therapeutics, Inc.(VRDN) | 750,000 | 750,000 | 0 | $17.06M | $14.38M | 6.78% | -$2.69M |
| Pliant Therapeutics, Inc.(PLRX) | 1,910,121 | 1,055,000 | -855,121 | $21.41M | $13.89M | 6.55% | -$7.52M |
| ABIVAX Société AnonymeADS(ABVX) | 2,128,773 | 1,648,523 | -480,250 | $24.52M | $12.07M | 5.69% | -$12.46M |
| Dynavax Technologies Corp | 1,326,234 | 860,000 | -466,234 | $14.77M | $10.98M | 5.18% | -$3.79M |
| Neurogene Inc.(NGNE) | 1,004,291 | 442,761 | -561,530 | $42.14M | $10.12M | 4.77% | -$32.02M |
| Evolus, Inc.(EOLS) | 1,170,000 | 895,524 | -274,476 | $18.95M | $9.89M | 4.66% | -$9.07M |
| Xenon Pharmaceuticals Inc.(XENE) | 0 | 245,272 | +245,272 | $0 | $9.61M | 4.53% | +$9.61M |
| Unicycive Therapeutics Inc | 8,559,000 | 10,980,000 | +2,421,000 | $3.49M | $8.72M | 4.11% | +$5.23M |
| Zura Bio LimitedCL A(ZURA) | 3,263,672 | 3,170,194 | -93,478 | $13.25M | $7.93M | 3.73% | -$5.33M |
| Autolus Therapeutics plcADS(AUTL) | 2,811,955 | 3,009,392 | +197,437 | $10.21M | $7.07M | 3.33% | -$3.14M |
| Jasper Therapeutics, Inc.(JSPR) | 322,380 | 322,380 | 0 | $6.06M | $6.89M | 3.25% | +$828.5K |
| Merus N V | 250,000 | 158,092 | -91,908 | $12.49M | $6.65M | 3.13% | -$5.84M |
| Dianthus Therapeutics, Inc.(DNTH) | 275,000 | 275,000 | 0 | $7.53M | $6.00M | 2.83% | -$1.53M |
| Helix Acquisition Corp IiCL A | 500,000 | 500,000 | 0 | $5.22M | $5.25M | 2.47% | +$25.1K |
| Upstream Bio, Inc.(UPB) | 0 | 300,000 | +300,000 | $0 | $4.93M | 2.32% | +$4.93M |
| Context Therapeutics Inc.(CNTX) | 6,934,982 | 4,683,711 | -2,251,271 | $13.59M | $4.92M | 2.32% | -$8.67M |
| Voyager Therapeutics, Inc.(VYGR) | 959,953 | 826,751 | -133,202 | $5.62M | $4.69M | 2.21% | -$928.0K |
| Oruka Therapeutics, Inc.(ORKA) | 514,659 | 228,803 | -285,856 | $12.61M | $4.44M | 2.09% | -$8.18M |
| Mereo BioPharma Group plcADS(MREO) | 0 | 1,150,000 | +1,150,000 | $0 | $4.03M | 1.90% | +$4.03M |
| Rezolute, Inc.(RZLT) | 0 | 621,894 | +621,894 | $0 | $3.05M | 1.44% | +$3.05M |
| Promis Neurosciences Inc | 2,790,698 | 2,645,128 | -145,570 | $3.49M | $2.51M | 1.18% | -$981.3K |
| Optinose Inc | 0 | 370,269 | +370,269 | $0 | $2.47M | 1.17% | +$2.47M |
| UroGen Pharma Ltd.(URGN) | 758,786 | 187,843 | -570,943 | $9.64M | $2.00M | 0.94% | -$7.64M |
| Arcellx Inc COMMON STOCK | 100,000 | 0 | -100,000 | $8.35M | $0 | — | -$8.35M |
| Cartesian Therapeutics, Inc.(RNAC) | 200,000 | 0 | -200,000 | $3.22M | $0 | — | -$3.22M |
| Climb Bio, Inc.(CLYM) | 248,168 | 0 | -248,168 | $1.26M | $0 | — | -$1.26M |
| Olema Pharmaceuticals, Inc.(OLMA) | 1,000,000 | 0 | -1,000,000 | $11.94M | $0 | — | -$11.94M |
| Optinose Inc | 12,861,136 | 0 | -12,861,136 | $8.62M | $0 | — | -$8.62M |
| Outlook Therapeutics, Inc.(OTLK) | 1,293,028 | 0 | -1,293,028 | $6.90M | $0 | — | -$6.90M |
| TScan Therapeutics, Inc.(TCRX) | 1,016,375 | 0 | -1,016,375 | $5.06M | $0 | — | -$5.06M |
| Vistagen Therapeutics, Inc.(VTGN) | 674,075 | 0 | -674,075 | $2.03M | $0 | — | -$2.03M |